Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
It is a weak, potassium-sparing diuretic that is used as an adjunct to thiazide diuretics such as hydrochlorothiazide and loop diuretics such as furosemide to conserve potassium.
It is used in the treatment of edema associated with liver cirrhosis and heart failure and in the treatment of hypertension. Oral administration once a day.
On latest update relevant data on breastfeeding were not found.
Long-term treatment with diuretic drugs may compromise the state of hydration of the nursing mother. Must make an adjustment (decrease) of the dose based on the estimated milk production and monitor milk production. Use a lower dose as possible, especially during the first postnatal month.
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable (WHO 2002), especially during the neonatal period and in the event of prematurity.